TABLE OF CONTENTS
1. INTRODUCTION 24
1.1. OBJECTIVES OF THE STUDY 24
1.2. MARKET DEFINITION 24
1.3. OVERVIEW OF EUROPE PHARMACEUTICAL PACKAGING MARKET 24
1.4. CURRENCY AND PRICING 25
1.5. LIMITATION 25
1.6. MARKETS COVERED 26
2. MARKET SEGMENTATION 28
2.1. MARKETS COVERED 28
2.2. GEOGRAPHIC SCOPE 29
2.3. YEARS CONSIDERED FOR THE STUDY 30
2.4. CURRENCY AND PRICING 30
2.5. RESEARCH METHODOLOGY 31
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7. SECONDARY SOURCES 35
2.8. ASSUMPTIONS 35
3. MARKET OVERVIEW 36
3.1. DRIVERS 38
?
3.2. RESTRAINTS 40
3.3. OPPORTUNITIES 41
3.4. CHALLENGES 42
4. EXECUTIVE SUMMARY 43
5. PREMIUM INSIGHTS 46
6. EUROPE PHARMACEUTICAL PACKAGING MARKET,
BY PRODUCT TYPE 49
6.1. OVERVIEW 48
6.2. DRUG DELIVERY 61
6.2.1. ORAL DRUGS 62
6.2.2. TOPICAL 62
6.2.3. OPHTHALMIC 63
6.2.4. NASAL 63
6.2.5. PULMONARY 63
6.2.6. TRANSDERMAL 63
6.2.7. OTHERS 63
6.3. VETERINARY VACCINES 64
6.3.1. LIVESTOCK VACCINES 65
6.3.2. PORCINE VACCINES 65
6.3.3. POULTRY VACCINES 66
6.3.4. CANINE VACCINES 66
6.3.5. FELINE VACCINES 66
6.3.6. EQUINE VACCINES 66
6.3.7. AQUACULTURE VACCINES 67
6.3.8. OTHERS 67
7. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 68
7.1. OVERVIEW 69
7.2. PLASTICS 71
7.2.1. HIGH-DENSITY POLYETHYLENE 72
7.2.2. POLYPROPYLENE 72
7.2.3. LOW-DENSITY POLYETHYLENE 73
7.2.4. OTHERS 73
7.3. PAPER AND PAPER BOARD 74
7.4. METALS 75
7.5. GLASS 76
7.6. OTHERS 77
8. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PURCHASE OF ORGANIZATION 78
8.1. OVERVIEW 79
8.2. MANUFACTURER 81
8.3. PACKAGING COMPANIES 82
8.4. GOVERNMENT AGENCIES 83
9. EUROPE PHARMACEUTICAL PACKAGINGS MARKET,
BY GEOGRAPHY 91
9.1. OVERVIEW 92
9.2. EUROPE 97
9.2.1. GERMANY 117
9.2.2. FRANCE 120
9.2.3. U.K. 123
9.2.4. ITALY 126
9.2.5. SPAIN 129
9.2.6. RUSSIA 132
9.2.7. TURKEY 135
9.2.8. BELGIUM 139
9.2.9. NETHERLANDS 141
9.2.10. SWITZERLAND 144
9.2.11. REST OF EUROPE 147
10. COMPANY LANDSCAPE 221
10.2. COMPANY SHARE ANALYSIS; EUROPE 222
11. COMPANY PROFILE. 226
11.1. BAUSCH + STR?BEL 287
11.1.1. COMPANY OVERVIEW 287
11.1.2. BAUSCH + STR?BEL MASCHINENFABRIK ILSHOFEN GMBH+CO. KG;COMPANY SNAPSHOT 287
11.1.3. PRODUCT PORTFOLIO 288
11.1.4. RECENT DEVELOPMENTS 288
11.2. ROBERT BOSCH GMBH (A SUBSIDIARY OF ROBERT BOSCH STIFTUNG GMBH) 289
11.2.1. COMPANY OVERVIEW 289
11.2.2. ROBERT BOSCH GMBH; REVENUE ANALYSIS 289
11.2.3. PRODUCT PORTFOLIO 290
11.2.4. RECENT DEVELOPMENTS 290
11.3. BECTON, DICKINSON AND COMPANY 291
11.3.1. COMPANY OVERVIEW 291
11.3.2. BECTON, DICKINSON AND COMPANY; REVENUE ANALYSIS 291
11.3.3. PRODUCT PORTFOLIO 292
11.3.4. RECENT DEVELOPMENTS 292
11.4. GERRESHEIMER AG 293
11.4.1. COMPANY OVERVIEW 293
11.4.2. REVENUE ANALYSIS 293
11.4.3. PRODUCT PORTFOLIO 294
11.4.4. RECENT DEVELOPMENTS 295
11.5. AMCOR LIMITED 296
11.5.1. COMPANY OVERVIEW 296
11.5.2. REVENUE ANALYSIS 296
11.5.3. PRODUCT PORTFOLIO 297
11.5.4. RECENT DEVELOPMENTS 297
11.6. APTAR GROUP, INC. 298
11.6.1. COMPANY OVERVIEW 298
11.6.2. REVENUE ANALYSIS 298
11.6.3. PRODUCT PORTFOLIO 299
11.6.4. RECENT DEVELOPMENTS 300
11.7. SCHOTT AG 301
11.7.1. COMPANY OVERVIEW 301
11.7.2. SCHOTT AG; REVENUE ANALYSIS 301
11.7.3. PRODUCT PORTFOLIO 302
11.7.4. RECENT DEVELOPMENTS 302
11.8. LONZA 303
11.8.1. COMPANY OVERVIEW 303
11.8.2. LONZA; REVENUE ANALYSIS 303
11.8.3. PRODUCT PORTFOLIO 304
11.8.4. RECENT DEVELOPMENTS 304
11.9. DU PONT 305
11.9.1. COMPANY OVERVIEW 305
11.9.2. DUPONT; REVENUE ANALYSIS 305
11.9.3. PRODUCT PORTFOLIO 306
11.9.4. RECENT DEVELOPMENTS 306
12. RELATED REPORTS 307
??